Year-over-year earnings per share growth for the last twelve months: elevaiskincare.com (ELAB)

Official company branding of Elevai Labs (ELAB)

Elevai Labs Inc. focuses on cellular biotechnologies for tissue regeneration, aiming for leadership in cosmeceuticals. The recorded quarterly EPS dynamics demonstrate a net income trend, where 100.20 serves as the base parameter value. The integration of exosomes into post-procedure care links the company with surgeons. Sales through clinics create a barrier to the mass market, ensuring high business margins.

Elevai Labs (ELAB) - Earnings per share growth in annualized terms for the last twelve months from 02/21/2024 to 11/15/2026

Analytical breakdowns for Elevai Labs Inc.

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Fundamental valuation:Elevai Labs Inc - ELAB
Flagship merchandise of elevaiskincare.com

Quarterly EPS growth measures the dynamics of net income per share, allowing investors to separate short-term fluctuations from the business's ability to offset rising operating expenses and inflation. By analyzing the quarterly EPS growth rate, an investor assesses the earnings stability of Elevai Labs Inc. (ELAB) against the backdrop of capital-intensive dermatological research and exosome patent protection, confirming the actual scaling of the business.

Competitor analysis

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel)|Year-over-year earnings per share growth for the last twelve months Oruka Pharma (ORKA)|Year-over-year net earnings per share change for the last twelve months Sanara MedTech|Quarterly EPS earnings growth DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Earnings per share growth in annualized terms for the last twelve months|DERM: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months FBRX (Forte Biosciences)|Empro Group (EMPG) - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year Sol-Gel Technologies Ltd. SLGL|Year-over-year net earnings per share growth for the last 12 months AXIL|Year-over-year net earnings per share growth for the last 12 months Medicus Pharma Ltd. (MDCX)|Quarterly EPS earnings growth VRCA|Year-over-year earnings per share growth rate for the last twelve months HOTH|Year-over-year earnings per share growth for the last twelve months biofrontera-us.com BFRI|Year-over-year earnings per one share growth for the last 12 months VYNE|SNOA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months QNRX (quoinpharma.com)|Azitra (AZTR) - Year-over-year earnings per share growth for the last twelve months|DRMA: Year-over-year earnings per share growth rate for the last twelve months|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth